| 1 |
Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins [J]. J Immunol, 1986, 136(7):2348-2357.
|
| 2 |
Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma [J]. Eur Respir J, 2014, 43(2):343-373.
|
| 3 |
Hartley R, Berair R, Brightling CE. Severe asthma: novel advances in the pathogenesis and therapy [J]. Pol Arch Med Wewn, 2014, 124(5):247-254.
|
| 4 |
Cosmi L, Maggi L, Santarlasci V, et al. T helper cells plasticity in inflammation [J]. Cytometry A, 2014, 85(1):36-42.
|
| 5 |
Talaat RM, Mohamed SF, Bassyouni IH, et al. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity [J]. Cytokine, 2015, 72(2):146-153.
|
| 6 |
Dolff S, Bijl M, Huitema MG, et al. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus [J]. Clin Immunol, 2011, 141(2):197-204.
|
| 7 |
7Semik-Orzech A, Barczyk A, Pierzchala W. The role of interleukin 17A in inducing neutrophilic inflammation in the pulmonary tract [J]. Pol Merkur Lekarski, 2007, 22(129):163-168.
|
| 8 |
Yang XO, Pappu BP, Nurieva R, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma [J]. Immunity, 2008, 28(1):29-39.
|
| 9 |
Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17＋T helper cells [J]. Cell, 2006, 126(6):1121-1133.
|
| 10 |
Zhang F, Fuss IJ, Yang Z, et al. Transcription of RORgammat in developing Th17 cells is regulated by E-proteins [J]. Mucosal Immunol, 2014, 7(3):521-532.
|
| 11 |
Solt L A, Kumar N, Nuhant P, et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand [J]. Nature, 2011, 472(7344):491-494.
|
| 12 |
Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation [J]. Semin Immunol, 2007, 19(6):409-417.
|
| 13 |
Nembrini C, Marsland BJ, Kopf M. IL-17-producing T cells in lung immunity and inflammation [J]. J Allergy Clin Immunol, 2009, 123(5):986-994, 995-996.
|
| 14 |
Pelletier M, Maggi L, Micheletti A, et al. Evidence for a cross-talk between human neutrophils and Th17 cells [J]. Blood, 2010, 115(2):335-343.
|
| 15 |
马超，任少敏，刘春枝. 不同严重程度支气管哮喘儿童诱导痰IL-17含量及炎症细胞百分比变化 [J]. 国际儿科学杂志, 2012, 39(3):316-318.
|
| 16 |
Irvin C, Zafar I, Good J, et al. Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma [J]. J Allergy Clin Immunol, 2014, 134(5):1175-1186.
|
| 17 |
McKinley L, Alcorn JF, Peterson A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice [J]. J Immunol, 2008, 181(6):4089-4097.
|
| 18 |
Newcomb DC, Boswell MG, Sherrill TP, et al. IL-17A induces signal transducers and activators of transcription-6-independent airway mucous cell metaplasia [J]. Am J Respir Cell Mol Biol, 2013, 48(6):711-716.
|
| 19 |
Ano S, Morishima Y, Ishii Y, et al. Transcription factors GATA-3 and RORgammat are important for determining the phenotype of allergic airway inflammation in a murine model of asthma [J]. J Immunol, 2013, 190(3):1056-1065.
|
| 20 |
Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 Cells [J]. Annu Rev Immunol, 2009, 27:485-517.
|
| 21 |
Bush A, Saglani S. Management of severe asthma in children [J]. Lancet, 2010, 376(9743):814-825.
|
| 22 |
Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma [J]. Am J Respir Crit Care Med, 2009, 180(5):388-395.
|
| 23 |
Wang L, Li Q, Wang L, et al. The role of Th17/IL-17 in the pathogenesis of primary nephrotic syndrome in children [J]. Kidney Blood Press Res, 2013, 37(4-5):332-345.
|
| 24 |
Zhao J, Lloyd CM, Noble A. Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling [J]. Mucosal Immunol, 2013, 6(2):335-346.
|
| 25 |
Vazquez-Tello A, Halwani R, Hamid Q, et al. Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells [J]. J Clin Immunol, 2013, 33(2):466-478.
|
| 26 |
Tsitoura DC, Rothman PB. Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells [J]. J Clin Invest, 2004, 113(4):619-627.
|
| 27 |
Liang Q, Guo L, Gogate S, et al. IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma [J]. J Immunol, 2010, 185(10):5704-5713.
|
| 28 |
Besnard AG, Sabat R, Dumoutier L, et al. Dual role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A [J]. Am J Respir Crit Care Med, 2011, 183(9):1153-1163.
|
| 29 |
Cosmi L, Maggi L, Santarlasci V, et al. Identification of a novel subset of human circulating memory CD4＋T cells that produce both IL-17A and IL-4 [J]. J Allergy Clin Immunol, 2010, 125(1):222-230.
|
| 30 |
Takahashi K, Hirose K, Kawashima S, et al. IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation [J]. J Allergy Clin Immunol, 2011, 128(5):1067-1076.
|
| 31 |
Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines [J]. J Allergy Clin Immunol, 2001, 108(3):430-438.
|
| 32 |
Bellini A, Marini MA, Bianchetti L, et al. Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients [J]. Mucosal Immunol, 2012, 5(2):140-149.
|
| 33 |
Al-Muhsen S, Letuve S, Vazquez-Tello A, et al. Th17 cytokines induce pro-fibrotic cytokines release from human eosinophils [J]. Respir Res, 2013, 14:34.
|
| 34 |
Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression [J]. J Allergy Clin Immunol, 2003, 111(6):1293-1298.
|
| 35 |
Chen Y, Thai P, Zhao YH, et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop [J]. J Biol Chem, 2003, 278(19):17036-17043.
|
| 36 |
Fujisawa T, Velichko S, Thai P, et al. Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm [J]. J Immunol, 2009, 183(10):6236-6243.
|
| 37 |
Hashimoto K, Durbin JE, Zhou W, et al. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels [J]. J Allergy Clin Immunol, 2005, 116(3):550-557.
|
| 38 |
Girodet PO, Ozier A, Bara I, et al. Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention [J]. Pharmacol Ther, 2011, 130(3):325-337.
|
| 39 |
Chang Y, Al-Alwan L, Risse PA, et al. Th17-associated cytokines promote human airway smooth muscle cell proliferation [J]. FASEB J, 2012, 26(12):5152-5160.
|
| 40 |
Chang Y, Al-Alwan L, Risse PA, et al. TH17 cytokines induce human airway smooth muscle cell migration [J]. J Allergy Clin Immunol, 2011, 127(4):1046-1053.
|
| 41 |
Kudo M, Melton AC, Chen C, et al. IL-17A produced by alphabeta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction [J]. Nat Med, 2012, 18(4):547-554.
|
| 42 |
Loirand G, Sauzeau V, Pacaud P. Small G proteins in the cardiovascular system: physiological and pathological aspects [J]. Physiol Rev, 2013, 93(4):1659-1720.
|
| 43 |
Pain M, Bermudez O, Lacoste P, et al. Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype [J]. Eur Respir Rev, 2014, 23(131):118-130.
|
| 44 |
Vittal R, Fan L, Greenspan DS, et al. IL-17 induces type V collagen overexpression and EMT via TGF-beta-dependent pathways in obliterative bronchiolitis [J]. Am J Physiol Lung Cell Mol Physiol, 2013, 304(6):L401-L414.
|
| 45 |
Busse WW, Holgate S, Kerwin E, et al. Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma [J]. Am J Respir Crit Care Med, 2013, 188(11):1294-1302..
|
| 46 |
Muranski P, Restifo NP. Essentials of Th17 cell commitment and plasticity [J]. Blood, 2013, 121(13):2402-2414.
|
| 47 |
Wang YH, Voo KS, Liu B, et al. A novel subset of CD4+ TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma [J]. J Exp Med, 2010, 207(11):2479-2491.
|
| 48 |
Corren J, Busse W, Meltzer EO, et al. A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma [J]. Am J Respir Crit Care Med, 2010, 181(8):788-796.
|
| 49 |
Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma [J]. N Engl J Med, 2011, 365(12):1088-1098.
|
| 50 |
Gauvreau GM, Boulet LP, Cockcroft DW, et al. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma [J]. Am J Respir Crit Care Med, 2011, 183(8):1007-1014.
|
| 51 |
Nicholson GC, Kariyawasam HH, Tan AJ, et al. The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge [J]. J Allergy Clin Immunol, 2011, 128(4):800-807.
|
| 52 |
Singh D, Kane B, Molfino NA, et al. A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma [J]. BMC Pulm Med, 2010, 10:3.
|
| 53 |
Wenzel S, Wilbraham D, Fuller R, et al. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies [J]. Lancet, 2007, 370(9596):1422-1431.
|
| 54 |
Newcomb DC, Boswell MG, Zhou W, et al. Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production [J]. J Allergy Clin Immunol, 2011, 127(4):1006-1013.
|
| 55 |
Newcomb DC, Boswell MG, Huckabee MM, et al. IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner [J]. J Immunol, 2012, 188(3):1027-1035.
|
| 56 |
Chen Z, Bai FF, Han L, et al. Targeting neutrophils in severe asthma via Siglec-9 [J]. Int Arch Allergy Immunol, 2018, 175(1-2):5-15.
|